Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2305

Journal of Obesity & Weight Loss Therapy received 2305 citations as per Google Scholar report

Journal of Obesity & Weight Loss Therapy peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • University of Bristol
  • Pubmed
  • ICMJE
Share This Page

Polyglucosamine in the treatment of overweight and obesity

4th International Conference and Exhibition on Obesity and Weight Management

Umberto Cornelli

Loyola University School of Medicine, United States

ScientificTracks Abstracts: J Obes Weight Loss Ther

DOI: 10.4172/2165-7904.C1.024

Abstract
Overweight and obesity are one of the major public health challenges of the 21st century and the capacity to face the problem using non-prescription medicine to support weight loss has been frequently criticized because of scarcity of preclinical data on body weight reduction and the poor clinical trials available. Polyglucosamine ( PG L112) is a LMWC (low molecular weight chitosan) that belongs to the category of the medical devices. It has been tested for the chemico-physical activity showing to be one of the best fat binder available [Froese WM, Ludlow ME. Food Nutr Sci 2014; 5: 1637-1643]. In particular previous studies documented that the product has very high affinity for oxidized lipids, which are known to be one of the main causes of gastrointestinal oxidative stress [Cornelli U et al. Phys Reg Med 2006; 1: 25- 29]. Pharmacological studies have clarified its mechanism of action in modifying the microbiota and increasing the glucose elimination in feces [Bondiolotti G e al. Europ J Pharmac 2007; 567:155-158, Bondiolotti et al. Food Chem 2011;124 :978-982]. Double blind studies in humans comparing PG L112 Vs placebo have shown that the product in combination with a diet is more effective than the combination of diet +placebo [Cornelli U et al. Minerva Cardioang 2008;56:71-78, Pokhis K et al. BMC Obesity 2015;2: 25]. Similarly, double blind studies in obese subjects comparing the product Vs Orlistat confirmed the significant superiority of PG L112 in the body weight reduction with an irrelevant incidence of side effects [Stoll M et al BMC Obesity 2015 in press].
Biography

Email: umbertocornelli@cornelliconsulting.it

Relevant Topics
Top